Towa Pharmaceutical Co., Ltd.

DB:6QC Stock Report

Market Cap: €973.3m

Towa Pharmaceutical Management

Management criteria checks 1/4

Towa Pharmaceutical's CEO is Itsuro Yoshida, appointed in Jun 1996, has a tenure of 28.58 years. directly owns 2.96% of the company’s shares, worth €28.77M. The average tenure of the management team and the board of directors is 1 years and 3.6 years respectively.

Key information

Itsuro Yoshida

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure28.6yrs
CEO ownership3.0%
Management average tenureless than a year
Board average tenure3.6yrs

Recent management updates

Recent updates

CEO

Itsuro Yoshida (73 yo)

28.6yrs

Tenure

Mr. Itsuro Yoshida has been the President at Towa Pharmaceutical Co. Ltd. since June 1996. Mr. Yoshida joined Towa Pharmaceutical Co., Ltd.in May 1979 and served as its Manager of Accounting since May 198...

Leadership Team

NamePositionTenureCompensationOwnership
Itsuro Yoshida
President & Representative Director28.6yrsno data2.96%
€ 28.8m
Shiro Hatagami
Executive Officer and GM of Accounting & Finance Divisionless than a yearno datano data
Norikazu Inoue
Executive Officer & GM of Administration Divisionless than a yearno data0.0024%
€ 23.7k
Shigeki Fujita
Operating Officer & GM of Human Resource Development Centerless than a yearno datano data
Yutaka Okuda
Senior OO & Division Manager of R&D Division and Unit Manager of Innovative Tech Research Unitless than a yearno datano data
Masao Tanaka
Directorno datano data0.016%
€ 152.2k
Tetsuro Tabata
Senior Executive Officer & GM of Production Divisionless than a yearno datano data
Takeshi Sugiura
Executive Officerno datano datano data
Yasuyuki Oishi
Executive Officerno datano datano data

1.0yrs

Average Tenure

70yo

Average Age

Experienced Management: 6QC's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Itsuro Yoshida
President & Representative Director41.1yrsno data2.96%
€ 28.8m
Masao Tanaka
Director7.6yrsno data0.016%
€ 152.2k
Masaaki Takeyasu
Directorless than a yearno data0.0014%
€ 13.8k
Nobuki Ando
Independent Outside Directorless than a yearno datano data
Norikazu Eiki
Independent Outside Director9.6yrsno datano data
Osamu Uchikawa
Director1.6yrsno data0.0045%
€ 43.5k
Kaori Oishi
Independent Outside Director4.6yrsno datano data
Kenryo Goto
Independent Outside Director3.6yrsno datano data
Toshikazu Kokubun
Directorless than a yearno data0.0018%
€ 17.8k

3.6yrs

Average Tenure

66yo

Average Age

Experienced Board: 6QC's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 19:37
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Towa Pharmaceutical Co., Ltd. is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Inc